Company Filing History:
Years Active: 2018-2022
Title: Martin Muenzel: Innovator in Diabetes Treatment
Introduction
Martin Muenzel is a notable inventor based in Broenshoej, Denmark. He has made significant contributions to the field of diabetes treatment through his innovative work on insulin derivatives. With a total of 2 patents, Muenzel's inventions are paving the way for advancements in medical therapies for diabetes.
Latest Patents
Muenzel's latest patents focus on insulin derivatives and their medical uses. The present invention is in the therapeutic fields of drugs for medical conditions relating to diabetes. More specifically, the invention relates to novel acylated derivatives of human insulin analogues. The invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives for the treatment or prevention of medical conditions relating to diabetes.
Career Highlights
Martin Muenzel is currently associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. His work at Novo Nordisk has allowed him to contribute to the development of innovative solutions for diabetes management.
Collaborations
Some of his notable coworkers include Peter Madsen and Susanne Hostrup, who have collaborated with him on various projects related to diabetes treatment.
Conclusion
Martin Muenzel's contributions to the field of diabetes treatment through his innovative patents highlight his role as a key inventor in the medical industry. His work continues to impact the lives of those affected by diabetes.